The share price of Charles River Laboratories International, Inc. (CRL) now
What analysts predict: $246.14
52-week High/Low: $262 / $181.22
50/200 Day Moving Average:
$206.22 / $211.43
This figure corresponds to the Average Price over the previous 50/200 days.
For Charles River Laboratories International stocks, the 50-day moving average is the resistance level today.
For Charles River Laboratories International stocks, the 200-day moving average is the resistance level today.
Are you interested in Charles River Laboratories International stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Charles River Laboratories International
stock price in 2026.
How much will one Charles River Laboratories International share be worth in
2026?
Is it worth taking profit / loss on Charles River Laboratories International stock now or waiting?
What are analysts' forecasts for Charles River Laboratories International stock?
We forecast Charles River Laboratories International stock performance using neural networks based on historical data on Charles River Laboratories International stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Charles River Laboratories International stock prediction results are shown below and presented as a graph, table and text information.
Charles River Laboratories International stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Charles River Laboratories International analysts is $246.14.
Today 200 Day Moving Average is the resistance level (211.43 $).
50 Day Moving Average is the resistance level (206.22 $).
Historical and forecast chart of Charles River Laboratories International stock
The chart below shows the historical price of Charles River Laboratories International stock and a prediction chart for the next year.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Charles River Laboratories International stock price can be found in the table below.
Charles River Laboratories International (CRL) Forecast for 2026
Month
Target
Pes.
Opt.
Vol., %
Jan
218.70
206.61
230.19
10.24 %
Feb
226.36
214.00
238.56
10.30 %
Mar
216.38
211.68
225.92
6.30 %
Apr
213.65
209.16
220.23
5.03 %
May
228.60
223.00
236.61
5.75 %
Jun
224.60
212.34
233.25
8.97 %
Jul
220.04
209.42
223.43
6.27 %
Aug
212.65
206.40
220.54
6.41 %
Sep
226.35
219.37
230.62
4.88 %
Oct
230.94
223.02
241.29
7.57 %
Nov
233.69
229.27
240.23
4.56 %
Dec
241.70
231.38
251.86
8.13 %
Charles River Laboratories International information and performance
Charles River Laboratories International, Inc., an early stage contract research company, provides drug discovery, non-clinical development and safety testing services in the United States, Europe, Canada, Asia Pacific and worldwide. It operates across three segments: Research Models and Services (RMS), Security Discovery and Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment manufactures and markets lines of research models and specially bred rats and mice for use by researchers.
Charles River Laboratories International Address
251 BALLARDVALE ST, WILMINGTON, MA, US
Market Capitalization:
10 796 219 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA:
952 821 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio:
21.84
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
1.195
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
9.64
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
-0.113
Quarterly Revenue Growth YOY:
0.089
Trailing PE:
21.84
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
17.39
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
3.719
Enterprise Value (EV) /Revenue
EV To EBITDA:
16.14
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
51271000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio:
N/A
Percent Insiders:
N/A
Percent Institutions:
N/A
Charles River Laboratories International price target for 2026 by month
Target values for the price of one Charles River Laboratories International share for Jan 2026.
The weighted average target price per Charles River Laboratories International share in Jan 2026 is: 218.70. In Jan, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.243% volatility is expected. Pessimistic target level: 206.61 Optimistic target level: 230.19
Target values for the price of one Charles River Laboratories International share for Feb 2026.
The weighted average target price per Charles River Laboratories International share in Feb 2026 is: 226.36. In Feb, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.295% volatility is expected. Pessimistic target level: 214.00 Optimistic target level: 238.56
Target values for the price of one Charles River Laboratories International share for Mar 2026.
The weighted average target price per Charles River Laboratories International share in Mar 2026 is: 216.38. In Mar, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 6.302% volatility is expected. Pessimistic target level: 211.68 Optimistic target level: 225.92
Target values for the price of one Charles River Laboratories International share for Apr 2026.
The weighted average target price per Charles River Laboratories International share in Apr 2026 is: 213.65. In Apr, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 5.025% volatility is expected. Pessimistic target level: 209.16 Optimistic target level: 220.23
Target values for the price of one Charles River Laboratories International share for May 2026.
The weighted average target price per Charles River Laboratories International share in May 2026 is: 228.60. In May, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 5.749% volatility is expected. Pessimistic target level: 223.00 Optimistic target level: 236.61
Target values for the price of one Charles River Laboratories International share for Jun 2026.
The weighted average target price per Charles River Laboratories International share in Jun 2026 is: 224.60. In Jun, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 8.965% volatility is expected. Pessimistic target level: 212.34 Optimistic target level: 233.25
Target values for the price of one Charles River Laboratories International share for Jul 2026.
The weighted average target price per Charles River Laboratories International share in Jul 2026 is: 220.04. In Jul, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 6.273% volatility is expected. Pessimistic target level: 209.42 Optimistic target level: 223.43
Target values for the price of one Charles River Laboratories International share for Aug 2026.
The weighted average target price per Charles River Laboratories International share in Aug 2026 is: 212.65. In Aug, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 6.412% volatility is expected. Pessimistic target level: 206.40 Optimistic target level: 220.54
Target values for the price of one Charles River Laboratories International share for Sep 2026.
The weighted average target price per Charles River Laboratories International share in Sep 2026 is: 226.35. In Sep, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 4.878% volatility is expected. Pessimistic target level: 219.37 Optimistic target level: 230.62
Target values for the price of one Charles River Laboratories International share for Oct 2026.
The weighted average target price per Charles River Laboratories International share in Oct 2026 is: 230.94. In Oct, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 7.571% volatility is expected. Pessimistic target level: 223.02 Optimistic target level: 241.29
Target values for the price of one Charles River Laboratories International share for Nov 2026.
The weighted average target price per Charles River Laboratories International share in Nov 2026 is: 233.69. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 4.562% volatility is expected. Pessimistic target level: 229.27 Optimistic target level: 240.23
Target values for the price of one Charles River Laboratories International share for Dec 2026.
The weighted average target price per Charles River Laboratories International share in Dec 2026 is: 241.70. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 8.128% volatility is expected. Pessimistic target level: 231.38 Optimistic target level: 251.86
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website